HEADER CYTOSKELETON 21-JAN-97 1AA2 TITLE CALPONIN HOMOLOGY (CH) DOMAIN FROM HUMAN BETA-SPECTRIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-SPECTRIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: F-ACTIN BINDING DOMAIN RESIDUES 173 - 281; COMPND 5 SYNONYM: CALPONIN HOMOLOGY (CH) DOMAIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGANELLE: NON-ERYTHROCYTE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACTERIUM; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: ESCHERICHIA COLI; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PBAT4 KEYWDS SPECTRIN, CYTOSKELETON, F-ACTIN CROSS-LINKING EXPDTA X-RAY DIFFRACTION AUTHOR K.DJINOVIC CARUGO,S.BANUELOS,M.SARASTE REVDAT 4 07-FEB-24 1AA2 1 REMARK REVDAT 3 24-FEB-09 1AA2 1 VERSN REVDAT 2 01-APR-03 1AA2 1 JRNL REVDAT 1 04-FEB-98 1AA2 0 JRNL AUTH K.DJINOVIC CARUGO,S.BANUELOS,M.SARASTE JRNL TITL CRYSTAL STRUCTURE OF A CALPONIN HOMOLOGY DOMAIN. JRNL REF NAT.STRUCT.BIOL. V. 4 175 1997 JRNL REFN ISSN 1072-8368 JRNL PMID 9164454 JRNL DOI 10.1038/NSB0397-175 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.FUKAMI,N.SAWADA,T.ENDO,T.TAKENAWA REMARK 1 TITL IDENTIFICATION OF A PHOSPHATIDYLINOSITOL REMARK 1 TITL 2 4,5-BISPHOSPHATE-BINDING SITE IN CHICKEN SKELETAL MUSCLE REMARK 1 TITL 3 ALPHA-ACTININ REMARK 1 REF J.BIOL.CHEM. V. 271 2646 1996 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.CASTRESANA,M.SARASTE REMARK 1 TITL DOES VAV BIND TO F-ACTIN THROUGH A CH DOMAIN? REMARK 1 REF FEBS LETT. V. 374 149 1995 REMARK 1 REFN ISSN 0014-5793 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.H.HARTWIG REMARK 1 TITL ACTIN-BINDING PROTEINS 1: SPECTRIN SUPERFAMILY REMARK 1 REF PROTEIN PROFILE V. 1 706 1994 REMARK 1 REFN ISSN 1070-3667 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT 5E REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 6831 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : A POSTERIORI REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.160 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.500 REMARK 3 FREE R VALUE TEST SET COUNT : 506 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.1600 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1600 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 7.50 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 506 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 6831 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 887 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 130 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 21.500 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.019 ; 2.400 ; 1824 REMARK 3 BOND ANGLES (DEGREES) : 2.059 ; 2.300 ; 2464 REMARK 3 TORSION ANGLES (DEGREES) : 24.114; 0.000 ; 1050 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.009 ; 6.000 ; 46 REMARK 3 GENERAL PLANES (A) : 0.016 ; 8.000 ; 258 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 7.609 ; 4.000 ; 912 REMARK 3 NON-BONDED CONTACTS (A) : 0.045 ; 20.000; 28 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : MOEWS & KRETSINGER (1975) J. MOL. BIOL. 91, 201 REMARK 3 -228. REMARK 3 KSOL : 0.75 REMARK 3 BSOL : 83.74 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : TNT PROTGEO REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : TNT BCORREL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE REPORTED RMS VALUES ARE UNWEIGHTED REMARK 4 REMARK 4 1AA2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170580. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : FEB-96 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR571 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NO OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6859 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 14.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : 0.08000 REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.01 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.04 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.26500 REMARK 200 R SYM FOR SHELL (I) : 0.31100 REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 30% PEG REMARK 280 8000, 100 MM SODIUM CACODYLATE, PH 6.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 26.84250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 5 CG NZ REMARK 480 PRO A 20 CG REMARK 480 ARG A 32 NH1 NH2 REMARK 480 GLN A 64 CD OE1 NE2 REMARK 480 LYS A 78 CD NZ REMARK 480 LYS A 93 NZ REMARK 480 LYS A 108 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 32 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 MET A 109 CG - SD - CE ANGL. DEV. = 9.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 26 -176.46 -171.77 REMARK 500 THR A 28 -92.32 -135.74 REMARK 500 ASP A 50 74.14 -103.53 REMARK 500 REMARK 500 REMARK: NULL DBREF 1AA2 A 2 109 UNP Q01082 SPTB2_HUMAN 173 280 SEQRES 1 A 108 LYS SER ALA LYS ASP ALA LEU LEU LEU TRP CYS GLN MET SEQRES 2 A 108 LYS THR ALA GLY TYR PRO ASN VAL ASN ILE HIS ASN PHE SEQRES 3 A 108 THR THR SER TRP ARG ASP GLY MET ALA PHE ASN ALA LEU SEQRES 4 A 108 ILE HIS LYS HIS ARG PRO ASP LEU ILE ASP PHE ASP LYS SEQRES 5 A 108 LEU LYS LYS SER ASN ALA HIS TYR ASN LEU GLN ASN ALA SEQRES 6 A 108 PHE ASN LEU ALA GLU GLN HIS LEU GLY LEU THR LYS LEU SEQRES 7 A 108 LEU ASP PRO GLU ASP ILE SER VAL ASP HIS PRO ASP GLU SEQRES 8 A 108 LYS SER ILE ILE THR TYR VAL VAL THR TYR TYR HIS TYR SEQRES 9 A 108 PHE SER LYS MET FORMUL 2 HOH *130(H2 O) HELIX 1 1 SER A 3 LYS A 15 1 13 HELIX 2 2 MET A 35 HIS A 44 1 10 HELIX 3 3 PRO A 46 LEU A 48 5 3 HELIX 4 4 PHE A 51 LYS A 53 5 3 HELIX 5 5 ALA A 59 LEU A 74 1 16 HELIX 6 6 PRO A 82 ILE A 85 1 4 HELIX 7 7 GLU A 92 SER A 107 1 16 CRYST1 31.471 53.685 32.197 90.00 106.25 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.031775 0.000000 0.009262 0.00000 SCALE2 0.000000 0.018627 0.000000 0.00000 SCALE3 0.000000 0.000000 0.032351 0.00000